(0.20%) 5 110.33 points
(0.32%) 38 363 points
(0.25%) 15 967 points
(-1.29%) $82.77
(6.34%) $2.05
(-0.10%) $2 344.90
(-0.27%) $27.46
(3.92%) $958.25
(-0.21%) $0.933
(-0.33%) $10.99
(-0.53%) $0.796
(1.66%) $93.40
2.23% INR 1 906.65
Live Chart Being Loaded With Signals
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally...
Stats | |
---|---|
Dagens volum | 79 230.00 |
Gjennomsnittsvolum | 190 653 |
Markedsverdi | 295.90B |
EPS | INR0 ( 2024-02-07 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-21 |
Last Dividend | INR9.25 ( 2023-08-16 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 58.41 |
ATR14 | INR2.88 (0.15%) |
Volum Korrelasjon
J. B. Chemicals & Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ASIANHOTNR.NS | 0.803 |
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
J. B. Chemicals & Korrelasjon - Valuta/Råvare
J. B. Chemicals & Økonomi
Annual | 2022 |
Omsetning: | INR31.49B |
Bruttogevinst: | INR27.65B (87.80 %) |
EPS: | INR26.50 |
FY | 2022 |
Omsetning: | INR31.49B |
Bruttogevinst: | INR27.65B (87.80 %) |
EPS: | INR26.50 |
FY | 2022 |
Omsetning: | INR24.24B |
Bruttogevinst: | INR15.61B (64.39 %) |
EPS: | INR49.86 |
FY | 2021 |
Omsetning: | INR20.06B |
Bruttogevinst: | INR12.88B (64.23 %) |
EPS: | INR57.96 |
Financial Reports:
No articles found.
J. B. Chemicals & Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR8.00 (N/A) |
INR0 (N/A) |
INR8.50 (N/A) |
INR0 (N/A) |
INR9.25 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.600 | 2003-06-30 |
Last Dividend | INR9.25 | 2023-08-16 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | INR149.65 | -- |
Avg. Dividend % Per Year | 1.66% | -- |
Score | 3.51 | -- |
Div. Sustainability Score | 4.86 | |
Div.Growth Potential Score | 5.35 | |
Div. Directional Score | 5.11 | -- |
Year | Amount | Yield |
---|---|---|
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.00 | 0.62% |
2019 | INR5.00 | 3.21% |
2020 | INR12.00 | 5.59% |
2021 | INR16.50 | 3.19% |
2022 | INR16.50 | 1.89% |
2023 | INR17.75 | 1.80% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SOBHA.NS | Dividend Junior | 2023-07-28 | Annually | 18 | 0.43% | |
MMP.NS | Dividend Junior | 2023-08-18 | Annually | 4 | 0.49% | |
HDFC.NS | Dividend Junior | 2023-05-16 | Annually | 23 | 0.85% | |
BHAGCHEM.NS | Dividend Junior | 2023-07-27 | Annually | 4 | 0.14% | |
RAIN.NS | Dividend Junior | 2023-05-19 | Annually | 18 | 0.39% | |
KIRLOSBROS.NS | Dividend Junior | 2023-07-25 | Annually | 17 | 0.99% | |
EMMBI.NS | Dividend Junior | 2023-08-04 | Annually | 14 | 0.28% | |
AKSHARCHEM.NS | No Dividend Player | 2023-09-20 | Annually | 7 | 0.34% | |
SUPRAJIT.NS | Dividend Junior | 2023-09-18 | Semi-Annually | 20 | 0.45% | |
NBIFIN.NS | Dividend Junior | 2023-08-11 | Sporadic | 8 | 0.01% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.152 | 1.500 | 6.96 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.198 | 1.500 | 8.91 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 59.22 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.16 | 2.00 | 5.28 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 14.16 | 2.00 | 2.92 | 5.84 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.890 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.855 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 56.51 | 1.000 | 4.39 | 0 | [1 - 100] |
returnOnEquityTTM | 0.198 | 2.50 | 9.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 14.16 | 2.00 | 5.28 | 5.84 | [0 - 30] |
dividendYielPercentageTTM | 0.540 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.16 | 2.00 | 5.28 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 8.97 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0648 | 1.000 | -0.879 | 0 | [0.1 - 0.5] |
Total Score | 5.35 |
J. B. Chemicals &
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.